Literature DB >> 19487542

MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.

Xiqiang Liu1, Jinsheng Yu, Lu Jiang, Anxun Wang, Fei Shi, Hui Ye, Xiaofeng Zhou.   

Abstract

MicroRNA deregulation is involved in tumor initiation and progression. The aim of this study was to identify and validate the microRNA candidates that contribute to the metastasis of oral tongue squamous cell carcinoma (OTSCC). Using microarrays, a panel of differentially expressed microRNAs was identified in paired OTSCC cell lines with different metastatic potential. Selected microRNA candidates (including hsa-miR-222) were further validated using quantitative PCR approach. Functional analysis indicated that hsa-miR-222 inhibits OTSCC cell invasion. Ectopic transfection of hsa-miR-222 reduced the expression of MMP1 and SOD2 in OTSCC cell lines. Direct targeting of hsa-miR-222 to specific sequences located in the 3'-untranslated regions of both MMP1 and SOD2 mRNAs were confirmed using luciferase reporter gene assays. Furthermore, SOD2 knockdown by siRNA led to the downregulation of MMP1 expression. Taken together, these results suggested that hsa-miR-222 regulates the MMP1 expression through both direct cis-regulatory mechanism (targeting MMP1 mRNA) and indirect trans-regulatory mechanism (indirect controlling of MMP1 gene expression by targeting SOD2). Our results indicate that hsa-miR-222 plays an important role in OTSCC invasion, and may serve as a novel therapeutic target for OTSCC patients at risk of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487542      PMCID: PMC2890246     

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

3.  Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.

Authors:  Eleftherios Vairaktaris; Christos Yapijakis; Spyridoula Derka; Zoe Serefoglou; Stavros Vassiliou; Emeka Nkenke; Vassilis Ragos; Antonis Vylliotis; Sofia Spyridonidou; Christos Tsigris; Athanasios Yannopoulos; Christina Tesseromatis; Friedrich W Neukam; Efstratios Patsouris
Journal:  Anticancer Res       Date:  2007 Jan-Feb       Impact factor: 2.480

4.  MicroRNA expression profiles in head and neck cancer cell lines.

Authors:  Nham Tran; Tessa McLean; Xiaoying Zhang; Chuan Jia Zhao; John Michael Thomson; Christopher O'Brien; Barbara Rose
Journal:  Biochem Biophys Res Commun       Date:  2007-04-09       Impact factor: 3.575

5.  Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis.

Authors:  Kristin K Nelson; Aparna C Ranganathan; Jelriza Mansouri; Ana M Rodriguez; Kirwin M Providence; Joni L Rutter; Kevin Pumiglia; James A Bennett; J Andres Melendez
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

6.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.

Authors:  Tyler E Miller; Kalpana Ghoshal; Bhuvaneswari Ramaswamy; Satavisha Roy; Jharna Datta; Charles L Shapiro; Samson Jacob; Sarmila Majumder
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

8.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

9.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

10.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Authors:  Naoto Kondo; Tatsuya Toyama; Hiroshi Sugiura; Yoshitaka Fujii; Hiroko Yamashita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

View more
  84 in total

1.  Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma.

Authors:  Angela J Yoon; Shuang Wang; Jing Shen; Nicolas Robine; Elizabeth Philipone; Martin W Oster; Albert Nam; Regina M Santella
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Computational methods for the identification of microRNA targets.

Authors:  Yang Dai; Xiaofeng Zhou
Journal:  Open Access Bioinformatics       Date:  2010-05-01

3.  Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

Authors:  Cheng Wang; Xiqiang Liu; Zujian Chen; Hongzhang Huang; Yi Jin; Antonia Kolokythas; Anxun Wang; Yang Dai; David T W Wong; Xiaofeng Zhou
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

4.  Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.

Authors:  Lu Jiang; Yang Dai; Xiqiang Liu; Cheng Wang; Anxun Wang; Zujian Chen; Caroline E Heidbreder; Antonia Kolokythas; Xiaofeng Zhou
Journal:  Hum Genet       Date:  2010-11-16       Impact factor: 4.132

5.  Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer.

Authors:  Jayshree Advani; Yashwanth Subbannayya; Krishna Patel; Aafaque Ahmad Khan; Arun H Patil; Ankit P Jain; Hitendra S Solanki; Aneesha Radhakrishnan; Sneha M Pinto; Nandini A Sahasrabuddhe; Joji K Thomas; Premendu P Mathur; Bipin G Nair; Xiaofei Chang; T S Keshava Prasad; David Sidransky; Harsha Gowda; Aditi Chatterjee
Journal:  OMICS       Date:  2017-07

6.  Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis.

Authors:  Yunfeng Yi; Jianming Chen; Changjie Jiao; Jing Zhong; Zhiming Song; Xiaoping Yu; Xiujuan Lu; Baoli Lin
Journal:  Oncol Lett       Date:  2016-10-05       Impact factor: 2.967

7.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.

Authors:  Zujian Chen; Yi Jin; Dongsheng Yu; Anxun Wang; Ishrat Mahjabeen; Cheng Wang; Xiqiang Liu; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2012-03-17       Impact factor: 5.337

Review 8.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

9.  MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.

Authors:  Manuela Ferracin; Barbara Zagatti; Lara Rizzotto; Francesco Cavazzini; Angelo Veronese; Maria Ciccone; Elena Saccenti; Laura Lupini; Andrea Grilli; Cristiano De Angeli; Massimo Negrini; Antonio Cuneo
Journal:  Mol Cancer       Date:  2010-05-26       Impact factor: 27.401

10.  Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

Authors:  Yuanyuan Li; David M Umbach; Leping Li
Journal:  Melanoma Res       Date:  2017-12       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.